Evidence map

ArticleCNS drugs2005

Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles.

Oliver Neuhaus et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2005
2006
2007
2008
2009
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 16185093